Shirazi thyme (Zataria multiflora) and asthma

What 2 graded rows on shirazi thyme (zataria multiflora) agree on for asthma, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Shirazi thyme (Zataria multiflora) page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Shirazi thyme (Zataria multiflora) page, with its PubMed record.

Supplement

Shirazi thyme (Zataria multiflora) Choose another

2 rows · 72 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade D, is a randomized trial of 36 people (2022) and found an improvement.

The rows run from 36 people, published from 2020 to 2022: 2 single studies.

2 improved

Grade DBlood inflammation markers in asthma · Improved
RCT · n 36 · 2022 · Adults with asthma (Mashhad, Iran)
5 or 10 mg/kg/day · 2 months
hs-CRP, total white cells, monocytes and eosinophils fell and lung-function values rose in both extract groups vs baseline. Haemoglobin and haematocrit fell with 10 mg/kg/day and MCV fell with both doses.
Row on the Shirazi thyme (Zataria multiflora) page · PubMed 34863879 (opens PubMed)
Grade DAsthma symptoms and lung function · Improved
RCT · n 36 · 2020 · Adults with asthma (Mashhad, Iran)
5 or 10 mg/kg/day in three daily doses · 2 months
Symptoms and lung-function tests improved at 1 and 2 months in both extract groups compared with their own baseline (p < 0.05 to p < 0.001); oxidative-stress and cytokine markers also improved vs baseline.
Row on the Shirazi thyme (Zataria multiflora) page · PubMed 32585581 (opens PubMed)